Asset Details
Do you wish to reserve the book?
Mycoplasma Pneumoniae : Susceptibility and Resistance To Antibiotics
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mycoplasma Pneumoniae : Susceptibility and Resistance To Antibiotics
Do you wish to request the book?
Mycoplasma Pneumoniae : Susceptibility and Resistance To Antibiotics
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mycoplasma Pneumoniae : Susceptibility and Resistance To Antibiotics
2011
Overview
Mycoplasma pneumoniae is a pathogenic mycoplasma responsible for respiratory tract infections in humans, which occurs worldwide in children and adults. This article focuses on its antibiotic susceptibility profile and on the development of acquired resistance in this microorganism. The lack of a cell wall in mycoplasmas makes them intrinsically resistant to β-lactams and to all antimicrobials that target the cell wall. M. pneumoniae is susceptible to macrolides and related antibiotics, tetracyclines and fluoroquinolones. Macrolides and related antibiotics are the first-line treatment for respiratory infections caused by M. pneumoniae. However, strains with acquired resistance to macrolides have recently emerged worldwide and have been spreading in Europe, USA and A sia especially, with more than 90% of Chinese isolates resistant to erythromycin and azithromycin. This acquired resistance can be detected by PCR methods directly from respiratory specimens and is related to 23S rRNA mutations.
Publisher
Future Medicine Ltd,Future Medicine
Subject
Anti-Bacterial Agents - pharmacology
/ Bacteria
/ Children
/ Fluoroquinolones - pharmacology
/ Humans
/ Mutation
/ Mycoplasma Infections - drug therapy
/ Mycoplasma Infections - microbiology
/ Mycoplasma pneumoniae - drug effects
/ Respiratory Tract Infections - drug therapy
/ Respiratory Tract Infections - microbiology
/ RNA
/ RNA, Ribosomal, 23S - genetics
/ rRNA
/ rRNA 23S
